Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SUI Group Holdings Ltd.SUIG · Entity 6997 | Director | January 05, 2026 | January 15, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SUI Group Holdings Ltd.
Report date January 05, 2026 · Filed January 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Warrant for Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $5.42 · Expires 2031-01-05 | Direct | 83,026 |
Reported balance
After 2026-01-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-01-05 · Grant · Acquired 83,026 · Balance 83,026 F1: Represents one-time equity grant as part of the Reporting Person's non-management director compensation upon his appointment to the Issuer's Board of Directors, effective January 5, 2026. F2: The warrants vest as follows: 25% of each tranche of the warrants become exercisable on July 5, 2026, 25% of each tranche of the warrants will become exercisable on January 5, 2027, 25% of each tranche of the warrants will become exercisable on July 5, 2027, and 25% of each tranche of the warrants will become exercisable on January 5, 2028. |
| Warrant for Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $5.96 · Expires 2031-01-05 | Direct | 41,513 |
Reported balance
After 2026-01-05 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-01-05 · Grant · Acquired 41,513 · Balance 41,513 F1: Represents one-time equity grant as part of the Reporting Person's non-management director compensation upon his appointment to the Issuer's Board of Directors, effective January 5, 2026. F2: The warrants vest as follows: 25% of each tranche of the warrants become exercisable on July 5, 2026, 25% of each tranche of the warrants will become exercisable on January 5, 2027, 25% of each tranche of the warrants will become exercisable on July 5, 2027, and 25% of each tranche of the warrants will become exercisable on January 5, 2028. |
| Warrant for Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $6.50 · Expires 2031-01-05 | Direct | 41,513 |
Reported balance
After 2026-01-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-01-05 · Grant · Acquired 41,513 · Balance 41,513 F1: Represents one-time equity grant as part of the Reporting Person's non-management director compensation upon his appointment to the Issuer's Board of Directors, effective January 5, 2026. F2: The warrants vest as follows: 25% of each tranche of the warrants become exercisable on July 5, 2026, 25% of each tranche of the warrants will become exercisable on January 5, 2027, 25% of each tranche of the warrants will become exercisable on July 5, 2027, and 25% of each tranche of the warrants will become exercisable on January 5, 2028. |
| Warrant for Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $7.05 · Expires 2031-01-05 | Direct | 41,513 |
Reported balance
After 2026-01-05 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-01-05 · Grant · Acquired 41,513 · Balance 41,513 F1: Represents one-time equity grant as part of the Reporting Person's non-management director compensation upon his appointment to the Issuer's Board of Directors, effective January 5, 2026. F2: The warrants vest as follows: 25% of each tranche of the warrants become exercisable on July 5, 2026, 25% of each tranche of the warrants will become exercisable on January 5, 2027, 25% of each tranche of the warrants will become exercisable on July 5, 2027, and 25% of each tranche of the warrants will become exercisable on January 5, 2028. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents one-time equity grant as part of the Reporting Person's non-management director compensation upon his appointment to the Issuer's Board of Directors, effective January 5, 2026.
F2: The warrants vest as follows: 25% of each tranche of the warrants become exercisable on July 5, 2026, 25% of each tranche of the warrants will become exercisable on January 5, 2027, 25% of each tranche of the warrants will become exercisable on July 5, 2027, and 25% of each tranche of the warrants will become exercisable on January 5, 2028.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 05, 2026 Filed Jan 15, 2026 16:59 UTC | SUI Group Holdings Ltd. SUIG · Entity 6997 | GrantWarrant for Common Stock · Derivative | 41,513 | $0.00 Strike: $7.05 | $0.00 |
DisclosureSEC source: 0001011438-26-000030 · form4.xml · derivative · entry 4 Quintenz Brian David · CIK 0002104670 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,513 Underlying: Common Stock · 41,513 shares Expires 2031-01-05 F1 · shares: Represents one-time equity grant as part of the Reporting Person's non-management director compensation upon his appointment to the Issuer's Board of Directors, effective January 5, 2026. F2 · derivative.exercise_date: The warrants vest as follows: 25% of each tranche of the warrants become exercisable on July 5, 2026, 25% of each tranche of the warrants will become exercisable on January 5, 2027, 25% of each tranche of the warrants will become exercisable on July 5, 2027, and 25% of each tranche of the warrants will become exercisable on January 5, 2028. Read SEC document |
| January 05, 2026 Filed Jan 15, 2026 16:59 UTC | SUI Group Holdings Ltd. SUIG · Entity 6997 | GrantWarrant for Common Stock · Derivative | 41,513 | $0.00 Strike: $6.50 | $0.00 |
DisclosureSEC source: 0001011438-26-000030 · form4.xml · derivative · entry 3 Quintenz Brian David · CIK 0002104670 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,513 Underlying: Common Stock · 41,513 shares Expires 2031-01-05 F1 · shares: Represents one-time equity grant as part of the Reporting Person's non-management director compensation upon his appointment to the Issuer's Board of Directors, effective January 5, 2026. F2 · derivative.exercise_date: The warrants vest as follows: 25% of each tranche of the warrants become exercisable on July 5, 2026, 25% of each tranche of the warrants will become exercisable on January 5, 2027, 25% of each tranche of the warrants will become exercisable on July 5, 2027, and 25% of each tranche of the warrants will become exercisable on January 5, 2028. Read SEC document |
| January 05, 2026 Filed Jan 15, 2026 16:59 UTC | SUI Group Holdings Ltd. SUIG · Entity 6997 | GrantWarrant for Common Stock · Derivative | 41,513 | $0.00 Strike: $5.96 | $0.00 |
DisclosureSEC source: 0001011438-26-000030 · form4.xml · derivative · entry 2 Quintenz Brian David · CIK 0002104670 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,513 Underlying: Common Stock · 41,513 shares Expires 2031-01-05 F1 · shares: Represents one-time equity grant as part of the Reporting Person's non-management director compensation upon his appointment to the Issuer's Board of Directors, effective January 5, 2026. F2 · derivative.exercise_date: The warrants vest as follows: 25% of each tranche of the warrants become exercisable on July 5, 2026, 25% of each tranche of the warrants will become exercisable on January 5, 2027, 25% of each tranche of the warrants will become exercisable on July 5, 2027, and 25% of each tranche of the warrants will become exercisable on January 5, 2028. Read SEC document |
| January 05, 2026 Filed Jan 15, 2026 16:59 UTC | SUI Group Holdings Ltd. SUIG · Entity 6997 | GrantWarrant for Common Stock · Derivative | 83,026 | $0.00 Strike: $5.42 | $0.00 |
DisclosureSEC source: 0001011438-26-000030 · form4.xml · derivative · entry 1 Quintenz Brian David · CIK 0002104670 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,026 Underlying: Common Stock · 83,026 shares Expires 2031-01-05 F1 · shares: Represents one-time equity grant as part of the Reporting Person's non-management director compensation upon his appointment to the Issuer's Board of Directors, effective January 5, 2026. F2 · derivative.exercise_date: The warrants vest as follows: 25% of each tranche of the warrants become exercisable on July 5, 2026, 25% of each tranche of the warrants will become exercisable on January 5, 2027, 25% of each tranche of the warrants will become exercisable on July 5, 2027, and 25% of each tranche of the warrants will become exercisable on January 5, 2028. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.